-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Share
Listen to the news

Gainers

  • ENvue Medical (NASDAQ:FEED) stock moved upwards by 19.0% to $1.25 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.1 million.
  • Pulsenmore (NASDAQ:PLSM) shares increased by 14.33% to $7.1. The market value of their outstanding shares is at $40.3 million.
  • Shuttle Pharmaceuticals (NASDAQ:SHPH) stock increased by 13.3% to $2.3. The market value of their outstanding shares is at $3.2 million.
  • Hyperliquid Strategies (NASDAQ:PURR) shares increased by 11.49% to $4.85. The company's market cap stands at $552.5 million.
  • Hyperion DeFi (NASDAQ:HYPD) stock rose 11.23% to $4.06. The company's market cap stands at $29.8 million.
  • Korro Bio (NASDAQ:KRRO) shares increased by 9.21% to $11.73. The market value of their outstanding shares is at $101.1 million.

Losers

  • Altimmune (NASDAQ:ALT) shares decreased by 13.4% to $5.35 during Wednesday's pre-market session. The market value of their outstanding shares is at $644.8 million.
  • Vyome Holdings (NASDAQ:HIND) stock decreased by 12.89% to $2.84. The company's market cap stands at $18.4 million.
  • USBC (AMEX:USBC) shares declined by 10.91% to $0.59. The company's market cap stands at $256.6 million.
  • Genenta Science (NASDAQ:GNTA) stock fell 10.39% to $1.38. The market value of their outstanding shares is at $36.0 million.
  • Nuwellis (NASDAQ:NUWE) stock fell 9.93% to $3.45. The company's market cap stands at $3.4 million.
  • BiomX (AMEX:PHGE) shares decreased by 9.07% to $6.32. The market value of their outstanding shares is at $10.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending